What is the recommended anticoagulant regimen for patients with fondaparinux undergoing PCI?
The recommended anticoagulant regimen for patients with fondaparinux undergoing PCI is UFH 85 IU/kg IV if no GP IIb/IIIa inhibitor is used and 60 IU/kg IV if a GP IIb/IIIa inhibitor is used with UFH dosing based on the target-activated clotting time, as suggested in the 2014 AHA/ACC NSTE-ACS Guideline.